Sign up for the QMED & MD+DI Daily newsletter.
September 2, 2022
2 Min Read
Second Sight Medical Products as the company has completed its merger with Nano Precision Medical and rebranded as Vivani Medical. The retinal prosthesis company was part of a failed merger with Pixium Vision last year.
A year after pulling its HeartWare Ventricular Assist Device (HVAD) System from the market, Medtronic is still dealing with regulatory issues associated with the device. The latest Medtronic recall relates to an increase in battery electrical faults due to an interaction between the HeartWare battery software and an internal component. This is the third recall associated with the HVAD System since the company discontinued it last year.
A new collaboration between Medtronic and BioIntelliSense, as well as Masimo's W1 launch, added some spice to the wearables space this week. Medtronic has agreed to distribute BioIntelliSense’s BioButton multi-parameter wearable designed for continuous, connected monitoring. Masimo announced a full market release of its W1 wrist-worn wearable for consumer use, and entered into a general launch phase for a medical version of the watch outside the United States. The medical version of Masimo W1 includes additional measurement capabilities including pot-check electrocardiogram (ECG), and atrial fibrillation (A-fib) detection.
And in case you missed our last Medtech in a Minute report...
AliveCor plans to exend its reach to patients via a series F round led by GE Healthcare. NGK-NTK (through a CVC partnership with Pegasus Tech Ventures) joined the round, along with existing investors Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, and WP Global Partners. The company will use the new funds to introduce subscription services, KardiaCare and KardiaComplete for patients, payers, and employers, and KardiaPro for physicians. These subscription services are supported by the company's personal ECG devices, including KardiaMobile, KardiaMobile 6L, and KardiaMobile Card. This financing will also allow for continued advancements in AliveCor's AI roadmap and pipeline of innovations.
Levita Magnetics raised $26 million in a series C financing. A health tech investment group managed by investor Evan Norton led the round, with additional participation from MedTex Ventures, Invermaster, and Carao Ventures, among returning investors. The financing will be used to support the regulatory and short-term commercial efforts for its Magnetic-Assisted Robotic Surgery (MARS) platform.
CathVision, a medical technology company developing electrophysiology (EP) solutions, raised $7.2 million in funding from existing investors. The funding is expected to help the company advance commercial operations for the ECGenius System and “support the continued development of artificial intelligence-powered analytic modules to provide electrophysiologists with unprecedented levels of automated analysis during cardiac ablation procedures.”
About the Author(s)
You May Also Like
Behind the Design of the Orchid Safety Release ValveFeb 27, 2024|4 Min Read
When Medical Device Design Had a Dimensional DilemmaFeb 27, 2024|2 Min Read
EU Council Endorse New Measures to Prevent Medical Device ShortagesFeb 27, 2024|2 Min Read
The Top 100 Medical Device CompaniesFeb 27, 2024|1 Min Read